Implantación de SAP R/3 en empresa comercial

El propósito del presente proyecto es el estudio de la implantación de un ERP (Enterprise Resource Planning) en una empresa del sector comercial que se dedica a la venta de perfumes y tiene diferentes comercios repartidos por todo el territorio nacional. Con esta aplicación se quiere controlar en tiempo real el stock y las ventas, y por otro lado se quiere automatizar el proceso de implantación de campañas de marketing y que los comercios apliquen los mismos precios en determinado momento.

Perimicrovillar membrane assembly: the fate of phospholipids synthesised by the midgut of Rhodnius prolixus

In this study, we describe the fate of fatty acids that are incorporated from the lumen by the posterior midgut epithelium of Rhodnius prolixus and the biosynthesis of lipids. We also demonstrate that neutral lipids (NL) are transferred to the haemolymphatic lipophorin (Lp) and that phospholipids remain in the tissue in which they are organised into perimicrovillar membranes (PMMs). 3H-palmitic acid added at the luminal side of isolated midguts of R. prolixus females was readily absorbed and was used to synthesise phospholipids (80%) and NL (20%). The highest incorporation of 3H-palmitic acid was on the first day after a blood meal. The amounts of diacylglycerol (DG) and triacylglycerol synthesised by the tissue decreased in the presence of Lp in the incubation medium. The metabolic fates of 3H-lipids synthesised by the posterior midgut were followed and it was observed that DG was the major lipid released to Lp particles. However, the majority of phospholipids were not transferred to Lp, but remained in the tissue. The phospholipids that were synthesised and accumulated in the posterior midgut were found to be associated with Rhodnius luminal contents as structural components of PMMs.

Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review).

There is strong evidence suggesting the presence of a genetic component in the aetiology of multiple myeloma (MM). However no genetic risk factors have been unequivocally established so far. To further our understanding of the genetic determinants of MM risk, a promising strategy is to collect a large set of patients in a consortium, as successfully done for other cancers. In this article, we review the main findings in the genetic susceptibility and pharmacogenetics of MM and present the strategy of the IMMEnSE (International Multiple Myeloma rESEarch) consortium in contributing to determine the role of genetic variation in pharmacogenetics and in MM risk.

Nova síntesi enantioselectiva de la (R)- i (S)-4-hidroxi-2-ciclohexenona

En el present treball de recerca s’ha plantejat la síntesi de forma enantioselectiva d’ambdós enantiòmers de la 4-hidroxi-2-ciclohexenona i derivats O-protegits. Així, s’ha dut a terme una aproximació sintètica a partir de la 1,4- ciclohexandiona parcialment protegida amb etilenglicol, per obtenir els dos enantiòmers de la molècula objectiu i derivats O-protegits, reproduint metodologies ja emprades en el nostre grup de recerca. D’aquesta manera, s’han obtingut ambdós enantiòmers del derivat O-protegit en un total de 5 passos, amb un rendiment del 60% i un 92% d’excés enantiomèric. Amb aquesta síntesi enantioselectiva s’aconsegueix una millora dels resultats del nostre grup de recerca, essent també una estratègia sintètica molt competitiva amb les que ja estan publicades tant pel bons rendiments obtinguts com per l’excés enantiomèric. L’accessibilitat del producte de partida i el fàcil escalatge de les reaccions fan d’aquesta estratègia sintètica una interessant opció a tenir en compte.

Implantació de SAP R/3 a una empresa del sector oleic

Implementació de SAP en una empresa del sector oleic per tal d'incorporar la informació corporativa en una infraestructura única que permeti tenir les dades d'una forma centralitzada, segura i fiable. Reestructuració dels processos, eliminant tasques repetitives i activitats que no aportin valor afegit, per millorar el servei al client.

Integració i gestió dels marcatges laborals del personal d'empresa al sistema SAP R/3

L'objectiu d'aquest projecte és realitzar l'estudi i el disseny per a la corresponent implantació d'un sistema de control dels marcatges per fer el traspàs i poder-los gestionar amb SAP R/3 en un grup d'empreses.

Implantación del sistema ERP SAP R/3

El objetivo del presente trabajo ha sido realizar un estudio de investigación y desarrollo sobre la implantación del sistema Enterprise Resource Planning (ERP) SAP R/3 de una empresa.

How to confirm C.E.R.A. doping in athletes' blood?

C.E.R.A. (Continuous Erythropoietin Receptor Activator) is a new third-generation erythropoiesis-stimulating agent that has recently been linked with abuse in endurance sports. The anti-doping community rapidly reacted by releasing a high-throughput screening ELISA allowing the detection of C.E.R.A. doping in athletes' blood. In order to return adverse analytical findings, anti-doping laboratories, however, need, as far as possible, to confirm the presence of the drug in athletes' samples through orthogonal methods. This article focuses on the comparison of 2 proposed confirmation assays based on gel electrophoresis that were coupled with a new sample immunopurification method. IEF, the classical method used to target erythropoietin (EPO) and its recombinant analogues in athletes' samples, and SARKOSYL-PAGE were applied to the plasma samples of subjects having received a single injection of C.E.R.A. It was demonstrated that SARKOSYL-PAGE was at least 6 times more sensitive than IEF, with comparable specificity. A longer detection window coupled with easier interpretation criteria led us to recommend the use of SARKOSYL-PAGE to confirm C.E.R.A. presence in athletes' blood.